BlueCross BlueShield Association (BCBSA) uses the criteria below to evaluate technology. A technology which, as determined by BCBSA, does not meet all five criteria is considered investigational.
The technology must have final approval from the appropriate government regulatory bodies.
The scientific evidence must permit conclusions concerning the effect of the technology on health outcomes.
The technology must improve the net health outcome.
The technology must be as beneficial as any established alternatives.
The improvement must be attainable outside the investigational settings.
This document has been classified as public information.